ROSE Diagnostics

Carlsbad, CA · Founded 2023 · Privately Held (backing)

Developer of lymph biomarkers designed for cancer diagnostics. ROSE Diagnostics is based in Carlsbad, CA and was founded in 2023. It has raised $3.4 million across 2 recorded rounds; the latest was a $2.3 million seed round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$3.4M
Last round
Seed Round
May 2025
No prints on record

No secondary trades in ROSE Diagnostics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of ROSE Diagnostics with a free Private Market View account
  • ·Watch ROSE Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where ROSE Diagnostics prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ROSE Diagnostics stock.